Nonpalpable Breast Cancer: Mammographic and Clinical findings

ACR Appropriateness Criteria® on nonpalpable mammographic findings (excluding calcifications).

Screening mammography can detect breast cancer before it becomes clinically apparent. However, the screening process identifies many false-positive findings for each cancer eventually confirmed. Additional tools are available to help differentiate spurious findings from real ones and to help determine when tissue sampling is required, when short-term follow-up will suffice, or whether the findi...

breast hamartoma: mammographic findings

Mammographic findings in different breast cancer subtypes (luminal, Her2 positive, triple negative)

Background: Prognosis and management of breast cancer are defined by different variables including histological type, grading, clinical stage, Her2+, estrogen and progesterone receptor conditions. Generally, mammography is one of the most important imaging which is done in breast cancer patients. The aim of this research was to evaluate different mammographic patterns in different breast cancer...

Breast Hamartoma: Mammographic Findings

Breast hamartoma is an uncommon, benign, slow-growing lesion found in all age groups after puberty. This pathological entity has a reported incidence of 1.2% of benign lesions and 4-8% of benign breast tumors in women (1, 2). It appears that with the increasing use of breast screening more hamartomas are likely to be identified. This rare pathological entity consists of a well-circum-scribed, b...

Mammographic Screening for Breast Cancer

1. Reisberg B, Doody R, Stöffler A, et al. Memantine in moderateto-severe Alzheimer’s disease. N Engl J Med 2003;348:1333-4. 2. Kornhuber J, Bormann J, Retz W, Hübers M, Riederer P. Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 1989;166:589-90. 3. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for de...